Patrick Hwu

42.0k total citations · 7 hit papers
220 papers, 15.8k citations indexed

About

Patrick Hwu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Patrick Hwu has authored 220 papers receiving a total of 15.8k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Oncology, 133 papers in Immunology and 74 papers in Molecular Biology. Recurrent topics in Patrick Hwu's work include Immunotherapy and Immune Responses (111 papers), Cancer Immunotherapy and Biomarkers (80 papers) and CAR-T cell therapy research (76 papers). Patrick Hwu is often cited by papers focused on Immunotherapy and Immune Responses (111 papers), Cancer Immunotherapy and Biomarkers (80 papers) and CAR-T cell therapy research (76 papers). Patrick Hwu collaborates with scholars based in United States, Australia and China. Patrick Hwu's co-authors include Nicholas P. Restifo, Steven A. Rosenberg, Willem W. Overwijk, Réjean Lapointe, Laszlo Radvanyi, Gregory Lizée, Yanyan Lou, Suzanne L. Topalian, Douglas J. Schwartzentruber and John R. Wunderlich and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Patrick Hwu

216 papers receiving 15.6k citations

Hit Papers

Cancer Regression and Aut... 2000 2026 2008 2017 2002 2014 2016 2009 2000 500 1000 1.5k 2.0k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Patrick Hwu 10.0k 9.4k 4.4k 1.6k 1.6k 220 15.8k
Taha Merghoub 6.3k 0.6× 6.9k 0.7× 4.3k 1.0× 1.2k 0.8× 1.2k 0.8× 210 12.5k
Udai S. Kammula 10.2k 1.0× 14.0k 1.5× 4.2k 1.0× 2.7k 1.7× 1.3k 0.8× 89 18.2k
Jonathan Cebon 6.6k 0.7× 6.3k 0.7× 4.7k 1.1× 1.4k 0.9× 1.2k 0.7× 278 13.6k
Barbara Seliger 8.1k 0.8× 6.3k 0.7× 5.3k 1.2× 896 0.6× 1.4k 0.9× 362 15.2k
Lawrence Fong 8.2k 0.8× 8.9k 0.9× 4.5k 1.0× 970 0.6× 2.9k 1.8× 268 16.2k
Michele W.L. Teng 8.3k 0.8× 9.2k 1.0× 3.6k 0.8× 716 0.4× 1.9k 1.2× 95 15.0k
Ena Wang 7.2k 0.7× 6.3k 0.7× 5.4k 1.2× 1.4k 0.9× 949 0.6× 260 14.2k
Patrick Hwu 7.7k 0.8× 10.8k 1.1× 6.6k 1.5× 2.1k 1.3× 2.4k 1.5× 200 17.4k
Phillip K. Darcy 7.5k 0.8× 9.2k 1.0× 3.9k 0.9× 1.7k 1.1× 876 0.5× 194 14.2k
Alan J. Korman 10.2k 1.0× 10.0k 1.1× 2.8k 0.6× 849 0.5× 1.5k 1.0× 113 15.6k

Countries citing papers authored by Patrick Hwu

Since Specialization
Citations

This map shows the geographic impact of Patrick Hwu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Hwu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Hwu more than expected).

Fields of papers citing papers by Patrick Hwu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Hwu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Hwu. The network helps show where Patrick Hwu may publish in the future.

Co-authorship network of co-authors of Patrick Hwu

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Hwu. A scholar is included among the top collaborators of Patrick Hwu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Hwu. Patrick Hwu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giuliano, Anna R., Barbara J. Kuter, Shari Pilon‐Thomas, et al.. (2023). Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients. Cancer Communications. 43(7). 749–764. 6 indexed citations
2.
Lucci, Anthony, Carolyn Hall, Sapna P. Patel, et al.. (2020). Circulating Tumor Cells and Early Relapse in Node-positive Melanoma. Clinical Cancer Research. 26(8). 1886–1895. 52 indexed citations
3.
Somaiah, Neeta, Matthew S. Block, Joseph W. Kim, et al.. (2019). First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1. Clinical Cancer Research. 25(19). 5808–5817. 71 indexed citations
4.
Peng, Weiyi, Leila J. Williams, Chunyu Xu, et al.. (2019). Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma. Clinical Cancer Research. 25(21). 6406–6416. 33 indexed citations
5.
Niknam, Sharareh, Hampartsoum B. Barsoumian, Jonathan E. Schoenhals, et al.. (2018). Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model. Clinical Cancer Research. 24(22). 5735–5743. 46 indexed citations
6.
Hu, Jiemiao, Chuang Sun, Chantale Bernatchez, et al.. (2018). T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors. Clinical Cancer Research. 24(12). 2920–2934. 62 indexed citations
7.
Park, Jungsun, Amjad H. Talukder, Seon Ah Lim, et al.. (2017). SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity. Cancer Immunology Research. 5(8). 618–629. 24 indexed citations
8.
Ritthipichai, Krit, Cara Haymaker, Xiaohui Yi, et al.. (2017). Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter. Clinical Cancer Research. 23(20). 6151–6164. 54 indexed citations
9.
Lou, Yanyan, Lixia Diao, Edwin R. Parra, et al.. (2016). Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma. Clinical Cancer Research. 22(14). 3630–3642. 349 indexed citations breakdown →
10.
Sim, Geok Choo, Chengwen Liu, Ena Wang, et al.. (2016). IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation. Cancer Immunology Research. 4(11). 983–994. 36 indexed citations
11.
Qin, Yong, Jason Roszik, Chandrani Chattopadhyay, et al.. (2016). Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma. Molecular Cancer Therapeutics. 15(10). 2442–2454. 41 indexed citations
12.
Bradley, Sherille D., Zeming Chen, Brenda Melendez, et al.. (2015). BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma. Cancer Immunology Research. 3(6). 602–609. 124 indexed citations
13.
Chacon, Jessica, Amod A. Sarnaik, Jie Qing Chen, et al.. (2014). Manipulating the Tumor Microenvironment Ex Vivo for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy. Clinical Cancer Research. 21(3). 611–621. 48 indexed citations
14.
Mittendorf, Elizabeth A., Anne V. Philips, Funda Meric‐Bernstam, et al.. (2014). PD-L1 Expression in Triple-Negative Breast Cancer. Cancer Immunology Research. 2(4). 361–370. 1065 indexed citations breakdown →
15.
Peng, Weiyi, Chengwen Liu, Chunyu Xu, et al.. (2012). PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-γ Inducible Chemokines. Cancer Research. 72(20). 5209–5218. 340 indexed citations
16.
Zhang, Minying, Sourindra N. Maiti, Chantale Bernatchez, et al.. (2012). A New Approach to Simultaneously Quantify Both TCR α- and β-Chain Diversity after Adoptive Immunotherapy. Clinical Cancer Research. 18(17). 4733–4742. 15 indexed citations
17.
Wu, Richard C., Shujuan Liu, Jessica Chacon, et al.. (2012). Detection and Characterization of a Novel Subset of CD8+CD57+ T Cells in Metastatic Melanoma with an Incompletely Differentiated Phenotype. Clinical Cancer Research. 18(9). 2465–2477. 19 indexed citations
18.
Martín‐Orozco, Natalia, Yufeng Li, Yi‐Jun Wang, et al.. (2010). Melanoma Cells Express ICOS Ligand to Promote the Activation and Expansion of T-Regulatory Cells. Cancer Research. 70(23). 9581–9590. 109 indexed citations
19.
Wang, Helen Y., Tihui Fu, Gang Wang, et al.. (2002). Induction of CD4+ T cell–dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells. Journal of Clinical Investigation. 109(11). 1463–1470. 78 indexed citations
20.
Moir, Susan, Angela Malaspina, Kisani M. Ogwaro, et al.. (2001). HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proceedings of the National Academy of Sciences. 98(18). 10362–10367. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026